Semaglutide prescription to be restricted to endocrinologists only: CDSCO panel tells Novo Nordisk Medical Dialogues Team11 Sept 2021 4:48 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has...
Semaglutide to be sold only on prescription of Endocrinologist, PG Medicine in India: CDSCO Committee Farhat Nasim22 Dec 2020 4:58 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has...
Novo Nordisk Once-weekly Insulin Icodec Shows Comparable Efficacy To Once-daily Insulin Glargine U100 in Phase 2 trial Ruchika Sharma15 Jun 2020 9:30 AM IST"Novo Nordisk has been at the forefront of insulin innovation for almost 100 years, and we continuously conduct disruptive research that can lead to...
FDA approves injection semaglutide for reducing major adverse CV events in patients with diabetes and known heart disease Medha Baranwal17 Jan 2020 10:22 AM ISTUSA: Semaglutide (Ozempic) injection 0.5 mg or 1 mg has received the US Food and Drug Administration (FDA) approval for the reduction of major adverse...
Novo Nordisk says Victoza helps lower heart risks savita thakur thakur6 March 2016 12:15 PM ISTCopenhagen: Novo Nordisk said on Friday the results from a trial showed that its Victoza diabetes drug significantly reduced the risks of major...
Sachin Tendulkar named brand ambassador for diabetes awareness campaign savita thakur thakur5 Jan 2016 11:22 AM ISTNovo Nordisk, world’s leading diabetes care company has announced cricketing legend Sachin Tendulkar as the brand ambassador for ‘changing diabetes’,...
Novo Nordisk diabetes drug fails to help heart failure -study Pooja Bhatia Bhatia9 Nov 2015 9:30 AM ISTOrlando :The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure,...
